Also trades as: AMG.DE (XETRA) · $vol 0M

$339.30

+1.88 (+0.56%)

Weekly Expected Move ±3.5%

$303 $315 $326 $338 $349

NASDAQ · Healthcare · Drug Manufacturers - General · Alpha Radar Neutral · Power 56 · $183.1B mcap · 538M float · 0.494% daily turnover · Short 55% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$36.7B +9.9% ▲

5Y CAGR: +7.6%

Gross Profit

$26.0B +26.5% ▲

5Y CAGR: +6.2%

Operating Income

$10.7B +47.1% ▲

5Y CAGR: +3.2%

Net Income

$7.7B +88.5% ▲

5Y CAGR: +1.2%

EPS (Diluted)

$14.23 +88.2% ▲

5Y CAGR: +2.9%

EBITDA

$15.8B +18.6% ▲

5Y CAGR: +4.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$26.0B	$26.3B	$28.2B	$33.4B	$36.7B
YoY Growth	+2.2%	+1.3%	+7.1%	+18.6%	+9.9%
Cost of Revenue	$6.5B	$6.4B	$8.4B	$12.9B	$10.7B
Gross Profit	$19.5B	$19.9B	$19.8B	$20.6B	$26.0B
Gross Margin	75.2%	75.7%	70.1%	61.5%	70.8%
R&D Expenses	$6.3B	$4.4B	$4.8B	$6.0B	$7.0B
SG&A Expenses	$5.4B	$5.4B	$6.2B	$7.1B	$7.0B
Operating Expenses	$11.9B	$10.4B	$11.8B	$13.3B	$15.3B
Operating Income	$7.6B	$9.6B	$7.9B	$7.3B	$10.7B
Operating Margin	29.4%	36.3%	28.0%	21.7%	29.1%
Interest Expense	$1.2B	$1.4B	$2.9B	$3.2B	$2.8B
Income Before Tax	$6.7B	$7.3B	$7.9B	$4.6B	$9.0B
Tax Expense	$808M	$794M	$1.1B	$519M	$1.3B
Net Income	$5.9B	$6.6B	$6.7B	$4.1B	$7.7B
Net Margin	22.7%	24.9%	23.8%	12.2%	21.0%
EPS (Diluted)	$10.28	$12.11	$12.49	$7.56	$14.23
EBITDA	$11.3B	$12.2B	$14.8B	$13.4B	$15.8B
Shares Outstanding	573M	541M	538M	541M	542M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$8.4B	$8.5B	$9.1B	$8.1B	$9.2B	$9.6B	$9.9B	$8.6B
Cost of Revenue	$3.2B	$3.3B	$3.1B	$3.0B	$3.0B	$3.1B	$1.8B	$2.7B
Gross Profit	$5.2B	$5.2B	$6.0B	$5.2B	$6.2B	$6.5B	$8.1B	$5.9B
Gross Margin	61.4%	61.1%	65.7%	63.6%	67.2%	67.8%	81.9%	68.2%
R&D Expenses	$1.4B	$1.4B	$1.7B	$1.5B	$1.7B	$1.9B	$2.2B	$1.7B
SG&A Expenses	$1.8B	$1.6B	$1.9B	$1.7B	$1.7B	$1.7B	$1.9B	$1.6B
Operating Expenses	$3.2B	$3.1B	$3.7B	$4.0B	$3.5B	$3.9B	$4.2B	$3.2B
Operating Income	$1.9B	$2.0B	$2.3B	$1.2B	$2.6B	$2.5B	$3.9B	$2.7B
Operating Margin	22.8%	24.1%	25.4%	14.5%	28.8%	26.4%	39.8%	30.9%
Interest Expense	$808M	$776M	$747M	$723M	$708M	$685M	$653M	$657M
Income Before Tax	$794M	$3.1B	$782M	$2.0B	$1.6B	$3.9B	$1.5B	$2.1B
Tax Expense	$48M	$271M	$155M	$243M	$136M	$705M	$181M	$265M
Net Income	$746M	$2.8B	$627M	$1.7B	$1.4B	$3.2B	$1.3B	$1.8B
Net Margin	8.9%	33.3%	6.9%	21.2%	15.6%	33.7%	13.5%	21.1%
EPS (Diluted)	$1.38	$5.22	$1.16	$3.20	$2.65	$5.93	$2.45	$3.34
EBITDA	$3.0B	$5.3B	$2.9B	$4.1B	$3.6B	$5.9B	$5.1B	$2.7B
Shares Outstanding	541M	542M	542M	541M	541M	542M	543M	544M

AMGN NASDAQ